Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 225

1.

[HPV vaccination is important for dermatologists].

Gross G.

Hautarzt. 2008 Nov;59(11):929-32. doi: 10.1007/s00105-008-1618-8. German.

PMID:
18936900
[PubMed - indexed for MEDLINE]
2.

Pediatricians' intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes.

Kahn JA, Zimet GD, Bernstein DI, Riedesel JM, Lan D, Huang B, Rosenthal SL.

J Adolesc Health. 2005 Dec;37(6):502-10.

PMID:
16310128
[PubMed - indexed for MEDLINE]
3.

Gynecologists' attitudes regarding human papilloma virus vaccination: a survey of Fellows of the American College of Obstetricians and Gynecologists.

Raley JC, Followwill KA, Zimet GD, Ault KA.

Infect Dis Obstet Gynecol. 2004 Sep-Dec;12(3-4):127-33.

PMID:
15763912
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

The cost-effectiveness of a quadrivalent human papillomavirus vaccine in Taiwan.

Dasbach EJ, Insinga RP, Yang YC, Pwu RF, Lac C, Elbasha EH.

Asian Pac J Cancer Prev. 2008 Jul-Sep;9(3):459-66.

PMID:
18990021
[PubMed - indexed for MEDLINE]
Free Article
5.

[Impact of prophylactic HPV vaccines on dermatology and venereology].

Gross G.

Hautarzt. 2007 Jun;58(6):507-14. Review. German.

PMID:
17497101
[PubMed - indexed for MEDLINE]
6.

HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives.

Castellsagué X, Schneider A, Kaufmann AM, Bosch FX.

Gynecol Oncol. 2009 Dec;115(3 Suppl):S15-23. doi: 10.1016/j.ygyno.2009.09.021. Epub 2009 Oct 12.

PMID:
19819540
[PubMed - indexed for MEDLINE]
7.

Vaccinating young adults against human papillomavirus: the importance of understanding health decision-making and behaviour.

Skinner SR, Kang M, Rosenthal SL.

Sex Health. 2007 Jun;4(2):129-32.

PMID:
17524291
[PubMed - indexed for MEDLINE]
8.

Potential barriers to HPV vaccine provision among medical practices in an area with high rates of cervical cancer.

Keating KM, Brewer NT, Gottlieb SL, Liddon N, Ludema C, Smith JS.

J Adolesc Health. 2008 Oct;43(4 Suppl):S61-7. doi: 10.1016/j.jadohealth.2008.06.015.

PMID:
18809147
[PubMed - indexed for MEDLINE]
9.

Human papillomavirus disease and vaccines.

Hutchinson DJ, Klein KC.

Am J Health Syst Pharm. 2008 Nov 15;65(22):2105-12. doi: 10.2146/ajhp070627. Review.

PMID:
18997137
[PubMed - indexed for MEDLINE]
10.

[Vaccination against human papillomavirus. Implementation and efficacy against cervical cancer control].

Bégué P, Henrion R, Blanc B, Girard M, Sancho-Garnier H.

Bull Acad Natl Med. 2007 Dec;191(9):1805-16; discussion 1816-7. French.

PMID:
18663976
[PubMed - indexed for MEDLINE]
11.

Cost-effectiveness evaluation of a quadrivalent human papillomavirus vaccine in Belgium.

Annemans L, Rémy V, Oyee J, Largeron N.

Pharmacoeconomics. 2009;27(3):231-45. doi: 10.2165/00019053-200927030-00006.

PMID:
19354343
[PubMed - indexed for MEDLINE]
12.

Human papillomavirus vaccine recommendations and agreement with mandated human papillomavirus vaccination for 11-to-12-year-old girls: a statewide survey of Texas physicians.

Kahn JA, Cooper HP, Vadaparampil ST, Pence BC, Weinberg AD, LoCoco SJ, Rosenthal SL.

Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2325-32. doi: 10.1158/1055-9965.EPI-09-0184.

PMID:
19661092
[PubMed - indexed for MEDLINE]
Free Article
13.
14.

Human papillomavirus vaccination of males: attitudes and perceptions of physicians who vaccinate females.

Weiss TW, Zimet GD, Rosenthal SL, Brenneman SK, Klein JD.

J Adolesc Health. 2010 Jul;47(1):3-11. doi: 10.1016/j.jadohealth.2010.03.003. Epub 2010 Apr 21.

PMID:
20547286
[PubMed - indexed for MEDLINE]
15.

Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial.

Muñoz N, Manalastas R Jr, Pitisuttithum P, Tresukosol D, Monsonego J, Ault K, Clavel C, Luna J, Myers E, Hood S, Bautista O, Bryan J, Taddeo FJ, Esser MT, Vuocolo S, Haupt RM, Barr E, Saah A.

Lancet. 2009 Jun 6;373(9679):1949-57. doi: 10.1016/S0140-6736(09)60691-7. Epub 2009 Jun 1.

PMID:
19493565
[PubMed - indexed for MEDLINE]
16.

HPV vaccination - a paradigm shift in public health.

May J.

Aust Fam Physician. 2007 Mar;36(3):106-11.

PMID:
17339969
[PubMed - indexed for MEDLINE]
Free Article
17.

Short version of the German evidence-based Guidelines for prophylactic vaccination against HPV-associated neoplasia.

Pathirana D, Hillemanns P, Petry KU, Becker N, Brockmeyer NH, Erdmann R, Gissmann L, Grundhewer H, Ikenberg H, Kaufmann AM, Klusmann J, Kopp I, Pfister H, Rzany B, Schneede P, Schneider A, Smola S, Winter-Koch N, Wutzler P, Gross G.

Vaccine. 2009 Jul 23;27(34):4551-9. doi: 10.1016/j.vaccine.2009.03.086. Epub 2009 Apr 17. Review.

PMID:
19524337
[PubMed - indexed for MEDLINE]
18.

Prevalence and predictors of human papillomavirus vaccination in adolescent girls.

Palli SR, Mehta S, Aparasu RR.

J Am Pharm Assoc (2003). 2012 Jan-Feb;52(1):52-8. doi: 10.1331/JAPhA.2012.10195.

PMID:
22257616
[PubMed - indexed for MEDLINE]
19.

A review of prophylactic human papillomavirus vaccines: recommendations and monitoring in the US.

Dunne EF, Datta SD, E Markowitz L.

Cancer. 2008 Nov 15;113(10 Suppl):2995-3003. doi: 10.1002/cncr.23763. Review.

PMID:
18980283
[PubMed - indexed for MEDLINE]
Free Article
20.

Reductions in human papillomavirus-disease resource use and costs with quadrivalent human papillomavirus (types 6, 11, 16, and 18) recombinant vaccination: the FUTURE Study Economic Evaluation.

Insinga RP, Dasbach EJ, Allen SE, Carides GW, Myers ER.

Value Health. 2008 Dec;11(7):1022-32. doi: 10.1111/j.1524-4733.2008.00342.x. Epub 2008 May 16.

PMID:
18489503
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk